ANALYSIS OF INDUCTION PHASE GLUCOCORTICOID USE ON ADRENAL SUPPRESSION IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Octaviana Simbolon, Yulistiani Yulistiani, I DG Ugrasena, Mariyatul Qibtiyah

= http://dx.doi.org/10.20473/fmi.v52i1.5197
Abstract views = 249 times | views = 388 times

Abstract


Glucocorticoids play an important role in the treatment of acute lymphoblastic leukemia (ALL). However, supraphysiological doses may cause suppression of the adrenal. Adrenal suppression resulting in reduced cortisol response may cause an inadequate host defence against infections, which remains a cause of morbidity and mortality in children with ALL. The occurrence of adrenal suppression before and after glucocorticoid therapy for childhood ALL is unclear. The aim of this study is to analysis the effect of glucocorticoid on cortisol levels during induction phase chemotherapy in children with acute lymphoblastic leukemia. A cross-sectional, observational prospective study was conducted to determine the effect of glucocorticoid on cortisol levels in children with acute lymphoblastic leukemia. Patients who met inclusion criteria were given dexamethasone or prednisone therapy for 49 days according to the 2013 Indonesian Chemotherapy ALL Protocol. Cortisol levels were measured on days 0, 14, 28, 42 and 56 of induction phase chemotherapy. There were 24 children, among 31 children recruited, who suffered from acute lymphoblastic leukemia. Before treatment, the means of cortisol levels were 228.95 ng/ml in standard risk group (prednisone) and 199.67 ng/ml in high risk group (dexamethasone). In standard risk group, the adrenal suppression occurs at about day 56. There was a significant decrement of cortisol levels in high risk group in days 14, 28, 42 against days 0 of induction phase (p=0.001). Both groups displayed different peak cortisol levels after 6 week of induction phase (p=0.028). Dexamethasone resulted in lower cortisol levels than prednisone during induction phase chemotherapy in children with acute lymphoblastic leukemia.

Keywords


glucocorticoid, acute lymphoblastic leukemia, cortisol levels, adrenal suppression

Full Text:

PDF

References


Ahmet A, Kim H, Spier S (2011). Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy, Asthma & Clinical Immunology 7, 1–12

Barrett E (2012). The adrenal gland. In: Walter FB & Emile LB (eds). Medical Physiology A Cellular and Molecular Approach, Philadelphia, Elsevier, p 1057–1065

Christensen M, et al (2005). Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. British Journal of Hematology 131, 50–58

Chrousos, Pavlaki AN, Magiakou MA (2011). Glucocorticoid therapy and adrenal suppression. Available from https://www.ncbi.nlm.nih.gov/books/ NBK279156/. Accessed January 15, 2015

Conter V, et al (2009). Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 24, 255–264

Einaudi S, et al (2008). Adrenal axis function after high-dose steroid therapy for childhood acute lympho-blastic leukemia. Pediatric Blood and Cancer 50, 537–541

Fauci A, Braunwald E, Kasper D (2008). Harrison’s Principles of Internal Medicine 17th ed, New York, McGraw-Hill Professional

Gordijn M, et al (2012). Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with gluco-corticoid therapy for childhood acute lymphoblastic leukaemia. Cochrane Database Syst Rev

Kaltkas G & Alexandraki K (2012). Adrenal Suppres-sion. Available from https://www.ncbi.nlm. nih.gov/ books/NBK279047/. Accessed April 20, 2015

Kuperman H, et al (2001). Evaluation of the hypothala-mic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy. Journal of Clinical Endocrinology & Metabolism 86, 2993–2996

Kuperman H, et al (2012). Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with prednisone or dexamethasone. Hormone Rese-arch in Paediatrics 78, 73–80

Miller D, Brueggmeler R, Dalton J (2008). Adrenocorti-coids. In: Lemke T & Williams D (eds). Foye’s Principles of Medicinal Chemistry, Philadelphia, Lippincott Williams & Wilkins, p 878–912

Miller W, Achermann J, Fluck C (2008). The adrenal cortex and its disorders. In: Sperling M (ed). Pediatric Endocrinology, Philadelphia, Saunders, p 455–457

Moisiadis V and Matthews S (2014). Glucocorticoid and fetal programming part 1: outcomes. Nature Review of Endocrinology 10, 391–402

Prucker C, et al (2009). Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster Study Group. Leukemia 23, 1264–1269

Pui C, et al (2000). Long-term results of total therapy studies 11, 12 and 13A for childhood acute lympho-blastic leukemia at St Jude Children’s Research Hospital. Leukemia 14, 2286–2294

Rix M, et al (2005). Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin study. The Journal of Pediatrics 147, 645–650

Schimmer B and Funder J (2011). ACTH, adrenal steroid, and pharmacology of the adrenal cortex. In: Brunton L (ed). Goodman and Gilman’s The Pharmacological Basis of Therapeutics 12th ed, New York, McGraw-Hill Comp, p 1994–1995

Shulman D, Palmert M, Kemp S (2007). Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 119, 484–494

Silverman L, et al (2000). Results of dana-farber cancer institute consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 14, 2247–2256

Siswandono and Purwanto (2000). Hubungan struktur-aktivitas hormon steroid. In: Siswandono and Soekardjo B (eds). Kimia Medisinal Jilid 2, Surabaya, Universitas Airlangga Press, p 423–434

Strehl C, Spies CM, Buttgereit F (2011). Pharmaco-dynamics of glucocorticoids. Clinical and Experiment-al Rheumatology 29, S13–S18

Venkatesh B and Cohen J (2008). Cortisol metabolism in inflammation and sepsis. Yearbook of Intensive Care and Emergency Medicine 2008, 514–519

White B (2010). The hypothalamus and pituitary gland. In: Berne and Levy (eds). Physiology 6th ed, Phila-delphia, Elsevier, p 706–724


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Folia Medica Indonesiana



                   

  

 

View My Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License